Citation only
via OpenAlex
Inflammation and the Redox‐sensitive AGE–RAGE Pathway as a Therapeutic Target in Alzheimer's Disease
Annette E. Maczurek, Kirubakaran Shanmugam, Gerald W Münch
Annals of the New York Academy of Sciences · 2008 · ▲ 60 citations
Abstract
Alzheimer's disease (AD) is the most common cause of dementia. Neuritic amyloid plaques and concomitant chronic inflammation are prominent pathological features of AD. beta-amyloid peptide (Abeta), the major component of plaques, and advanced glycation end products (AGEs), post-translational protein modifications, are key activators of plaque-associated inflammation. Abeta, AGEs, S100b, and amphoterin bind to the receptor for AGEs (RAGE), which transmits the signal from RAGE via redox-sensitive pathways to nuclear factor kappa-B (NF-kappaB)-regulated cytokines. RAGE-mediated inflammation caused by glial cells and subsequent changes in neuronal glucose metabolism are likely to be important contributors to neurodegeneration in AD. As long as the neuronal damage is reversible, drugs interfering with the Abeta and AGE-RAGE pathways might be interesting novel therapeutics for the treatment of AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1196/annals.1433.026
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Maczurek, A.E., Shanmugam, K., & Münch, G.W. (2008). Inflammation and the Redox‐sensitive AGE–RAGE Pathway as a Therapeutic Target in Alzheimer's Disease. <em>Annals of the New York Academy of Sciences</em>. https://doi.org/10.1196/annals.1433.026
Vancouver
Maczurek AE, Shanmugam K, Münch GW. Inflammation and the Redox‐sensitive AGE–RAGE Pathway as a Therapeutic Target in Alzheimer's Disease. Annals of the New York Academy of Sciences. 2008. doi:10.1196/annals.1433.026.
BibTeX
@article{annette2008Inflam,
title = {Inflammation and the Redox‐sensitive AGE–RAGE Pathway as a Therapeutic Target in Alzheimer's Disease},
author = {Annette E. Maczurek and Kirubakaran Shanmugam and Gerald W Münch},
journal = {Annals of the New York Academy of Sciences},
year = {2008},
doi = {10.1196/annals.1433.026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
World Journal of Diabetes 2014
Open access · CC-BY
Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart
Antioxidants 2025
Open access · CC-BY
Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective
MedComm 2026
Citation only
Advanced Glycation End Products: From Pathogenesis to Treatment.
Journal of Parkinson s Disease 2018
Open access · CC-BY
Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson’s Disease
Cells 2020
Open access · CC-BY
Peroxisome Proliferator-Activated Receptors and Caloric Restriction—Common Pathways Affecting Metabolism, Health, and Longevity
Biomolecules 2019
Open access · CC-BY